Bioavailability Study of Five Tablet Formulations of Dabigatran Etexilate Compared to Commercial Capsule Formulation in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 22, 2016

Primary Completion Date

May 11, 2016

Study Completion Date

June 10, 2016

Conditions

Healthy

Interventions

DRUG

Dabigatran etexilate tablet E1

DRUG

Dabigatran etexilate tablet D1

DRUG

Dabigatran etexilate tablet C1

DRUG

Dabigatran etexilate tablet B1

DRUG

Dabigatran etexilate tablet A1

DRUG

Dabigatran etexilate capsule

Trial Locations (1)

SOUSEIKAI Sumida Hospital, Tokyo, Sumida-ku